The platform is an end-to-end, fully integrated solution that will combine longitudinal patient data, biomarkers, machine learning, and data science to interpret respiratory changes in patients.
PneumoWave will provide patients, clinicians and researchers with real-time physiological data and patient-centric biomarkers to predict, monitor, detect and alert to respiratory adverse events in hospitals and at home.
The resulting insights will be leveraged to help discover and develop novel treatments with greater therapeutic potential and safety.
PneumoWave is under development – performance characteristics have not been established.
PNEUMOWAVE is a Digital Therapeutic company developing innovative technology to address global healthcare problems. Our technology will provide real-time feedback driven by physiological data and patient-centric biomarkers to detect, monitor and predict respiratory conditions.
PNEUMOWAVE is an end-to-end, fully integrated platform combining longitudinal patient data, biomarkers and machine learning to decode and interpret respiratory changes. The resulting insights will produce more rapid, targeted and effective intervention and prevention strategies for patients with a variety of respiratory diseases.
Commercial, clinical and technology partners.
Be the first to hear about our latest news